$45million fundraising endorses Microsulis menorrhagia technology
This article was originally published in Clinica
Executive Summary
Microsulis has completed a $45m fundraising with venture capital firm 3i understood to have invested about $25m in the round. A second global venture capital group and new and existing private investors provided the remainder.